Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Liabilities and Shareholders Equity (2016 - 2025)

Utah Medical Products has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $122.5 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $122.5 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $487.8 million (down 5.77% YoY), and the annual figure for FY2025 was $122.5 million, changed 0.0%.
  • Liabilities and Shareholders Equity for Q4 2025 was $122.5 million at Utah Medical Products, roughly flat from $122.0 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for UTMD hit a ceiling of $135.5 million in Q4 2023 and a floor of $114.4 million in Q1 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $122.5 million (2024), compared with a mean of $123.8 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 12.8% in 2021 and later fell 9.54% in 2025.
  • Utah Medical Products' Liabilities and Shareholders Equity stood at $115.6 million in 2021, then increased by 7.12% to $123.9 million in 2022, then grew by 9.35% to $135.5 million in 2023, then fell by 9.54% to $122.5 million in 2024, then grew by 0.0% to $122.5 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $122.5 million (Q4 2025), $122.0 million (Q3 2025), and $120.8 million (Q2 2025) per Business Quant data.